Skip to main content
. 2018 Jun 26;9(49):29047–29063. doi: 10.18632/oncotarget.25540

Figure 5. PI3K and Src inhibition lead to decreased OSCC invasion.

Figure 5

(A) UMSCC1 cells were plated in the upper chamber and incubated in the presence or absence of TNFα (10 ng/mL) without or with inhibitors. Cell invasion was calculated as the average cell coverage area under the membrane after 24-hour incubation. Two-way ANOVA followed by Bonferroni post hoc test: *P < 0.05 for TNFα (10 ng/mL) control vs. unstimulated control. **, P < 0.01; ***, P < 0.001 for inhibitor treatment vs. TNFα (10 ng/mL) control. (B) Representative western blot showing the expression of PAKT in UMSCC1 cells following TNFα (10 ng/mL) stimulation without or with inhibitors. Representative blot of 3 experiments. Columns represent the intensity of phospho-AKT ± SEM. One-way ANOVA followed by Dunnett’s multiple comparison test: *P < 0.05; **, P < 0.01; ***, P < 0.001